Related references
Note: Only part of the references are listed.Comparison of Hypersensitivity Reactions to PEG-Asparaginase in Children After Intravenous and Intramuscular Administration
Keith J. August et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2013)
Comparison of allergic reactions to pegasparaginase given intravenously versus intramuscularly
Mahati Pidaparti et al.
PEDIATRIC BLOOD & CANCER (2012)
Polyethylene Glycol-conjugated L-asparaginase Versus Native L-asparaginase in Combination With Standard Agents for Children With Acute Lymphoblastic Leukemia in Second Bone Marrow Relapse: A Children's Oncology Group Study (POG 8866)
Joanne Kurtzberg et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2011)
Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia
Lewis B. Silverman et al.
BLOOD (2010)
Peg-asparaginase for acute lymphoblastic leukemia
Michael Rytting
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Tolerability and Efficacy of L-Asparaginase Therapy in Pediatric Patients With Acute Lymphoblastic Leukemia
Elizabeth A. Raetz et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2010)
Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study
I. M. Appel et al.
LEUKEMIA (2008)
Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia
A Pession et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia:: a Children's Cancer Group study
VI Avramis et al.
BLOOD (2002)
A pharmacoeconomic analysis of pegaspargase versus native Escherichia coli L-asparaginase for the treatment of children with standard-risk, acute lymphoblastic leukemia: The Children's Cancer Group Study (CCG-1962)
HA Kurre et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2002)
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01
LB Silverman et al.
BLOOD (2001)
Share Paper
